P

Vaxcyte
D

PCVX

79.665
USD
-2.79
(-3.38%)
مغلق
حجم التداول
55,922
الربح لكل سهم
-4
العائد الربحي
-
P/E
-17
حجم السوق
9,929,170,437
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AAPL
    AAPL
    -0.310
    (-0.13%)
    245.560 USD
    AMZN
    AMZN
    -6.305
    (-2.83%)
    216.495 USD
    F
    F
    -0.09500
    (-1.01%)
    9.29000 USD
    GE
    GE
    -8.950
    (-4.29%)
    199.870 USD
    GOOGL
    GOOGL
    -4.895
    (-2.65%)
    179.685 USD
    MSFT
    MSFT
    -7.96
    (-1.91%)
    408.15 USD
    N
    NIO
    0.07500
    (1.72%)
    4.44500 USD
    N
    NKLA
    -0.05810
    (-13.20%)
    0.38200 USD
    TSLA
    TSLA
    -16.87
    (-4.76%)
    337.50 USD
    المزيد
الأخبار
المقالات

العنوان: Vaxcyte

القطاع: Healthcare
الصناعة: Biotechnology
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.